MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment

    J.W. Park, H.K. Yoon, M.H. Park, D.Y. Kwon (Ansan, Korea)

    Objective: To examine relationship between olfactory dysfunction and PD-MCI, and investigated the patterns of olfactory function in subtypes of PD-MCI patients using the Korean version…
  • 2016 International Congress

    Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease

    E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)

    Objective: We sought to determine: a) the ability of TYM to discriminate between PD patients with and without cognitive deficits b) equivalence between MoCA scores…
  • 2016 International Congress

    Gender differences in DLB: frequency, clinical presentation and treatment

    S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)

    Objective: To describe demographic and clinical characteristics and use of cholinesterase inhibitors in women and men diagnosed with DLB. Background: DLB seems to be more…
  • 2016 International Congress

    Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)

    Objective: We assume that the cerebrovascular disease might influence on the course and clinical features of dementia with Lewy bodies (DLB). The aim of this…
  • 2016 International Congress

    FYN expression is associated with regulatory region genetic variation

    L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

    Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation…
  • 2016 International Congress

    MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study

    R. Biundo, L. Weis, S. Bostantjopoulou, E. Stefanova, C. Falup-Pecurariu, M.G. Kramberger, G. Geurtsen, A. Antonini, D. Weintraub, D. Aarsland (Venice, Italy)

    Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…
  • 2016 International Congress

    The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

    S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)

    Objective: The objective of this study was to identify metabolic group differences between Idiopatic Parkinson's disease patients with dementia (PDD) and without dementia (PD), by…
  • 2016 International Congress

    Neuropsychology and magnetic resonance correlation in Parkinson´s disease mild cognitive impairment: Case-control study

    L.F.R. Vasconcellos, M. Adachi, D. Greca, M. Cruz, A.L. Malak, H. Charchat-Fichman, J.S. Pereira (Rio de Janeiro, Brazil)

    Objective: Evaluate the relationship between magnetic resonance (MRI) abnormalities and neuropsychological assessment in Parkinson s disease mild cognitive impairment (PD-MCI) and controls with mild cognitive…
  • 2016 International Congress

    Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

    T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)

    Objective: The our intention was to investigate a dynamics of cognitive decline in patients with different side of onset parkinsonism in view of visual dysfunction…
  • 2016 International Congress

    Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

    S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

    Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 1658
  • 1659
  • 1660
  • 1661
  • 1662
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley